Treatment of Hepatoblastoma With Drug-eluting Bead Transarterial Chemoembolization in a 13-Month-Old Infant: A Case Report and Review of the Literature.
J Pediatr Hematol Oncol
; 43(1): e123-e126, 2021 01.
Article
in En
| MEDLINE
| ID: mdl-32459718
ABSTRACT
BACKGROUND:
Prior reports have shown the utility of conventional lipiodol-based transarterial chemoembolization in hepatoblastoma. The authors describe the first reported case of hepatoblastoma treated with drug-eluting bead transarterial chemoembolization (DEB-TACE). OBSERVATIONS An 11-month-old infant presented with hepatoblastoma measuring 14.3 cm. A trial of cisplatin chemotherapy followed by sequential DEB-TACE to the tumor's feeding vasculature reduced the mass to 5.3 cm. The patient tolerated both sessions of DEB-TACE without any major complication. Having demonstrated adequate disease control, the patient then underwent successful liver transplantation.CONCLUSION:
This report provides promising evidence for the treatment of hepatoblastoma with DEB-TACE.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Liver Transplantation
/
Cisplatin
/
Chemoembolization, Therapeutic
/
Hepatoblastoma
/
Liver Neoplasms
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Female
/
Humans
/
Infant
Language:
En
Journal:
J Pediatr Hematol Oncol
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
/
PEDIATRIA
Year:
2021
Document type:
Article